Health Affairs, 25, no. 4 (2006): 1061-1069
doi: 10.1377/hlthaff.25.4.1061
© 2006 by Project HOPE
 
New Online
 * Getting Health Reform Done
 * After the State of the Union
 * Incremental Reform
 * E-Health in Developing World
 * Most-Read Articles in 2009
This Article
* Figures Only
* Full Text (HTML)
* Reprint (PDF)
* Submit a response to this article
* Alert me when this article is cited
* Alert me when Comments are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Similar articles in Web of Science
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Web of Science (3)
* Citing Articles via Google Scholar
Google Scholar
* Articles by Milstien, J. B.
* Articles by Kieny, M. P.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Milstien, J. B.
* Articles by Kieny, M. P.
Related Collections
* Access To Care
* Health Promotion/Disease Prevention
* International Issues
* Business Of Health
* Public Health
* Consumer Issues
* Vaccines

Health Tracking

MARKETWATCH

The Impact Of Globalization On Vaccine Development And Availability

Julie B. Milstien, Miloud Kaddar and Marie Paule Kieny

Globalization is likely to affect many aspects of public health, one of which is vaccine-preventable communicable diseases. Important forces include increased funding initiatives supporting immunization at the global level; regulatory harmonization; widespread intellectual property rights provisions through the World Trade Organization agreements; the emergence of developing-country manufacturers as major players in vaccine supply; and the appearance of new communicable disease threats, including those potentially linked to bioterrorism. All of these forces can affect, either positively and negatively, the development and availability of vaccines. Harnessing these will be a challenge for policymakers and immunization stakeholders.


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?


This article has been cited by other articles:


Home page
BMJHome page
D. A Chokshi and A. S Kesselheim
Rethinking global access to vaccines
BMJ, April 5, 2008; 336(7647): 750 - 753.
[Full Text] [PDF]